# Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer

> **NCT03721120** · NA · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 319 (actual)

## Conditions studied

- Metastatic Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** InvisionFirst® molecular panel

## Key facts

- **NCT ID:** NCT03721120
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03721120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03721120, "Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03721120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*